background
rna
coronaviru
respons
pandem
sever
acut
respiratori
syndrom
rna
virus
character
high
mutat
rate
million
time
higher
host
viru
mutagen
capabl
depend
upon
sever
factor
includ
fidel
viral
enzym
replic
nucleic
acid
rna
depend
rna
polymeras
rdrp
mutat
rate
drive
viral
evolut
genom
variabl
therebi
enabl
virus
escap
host
immun
develop
drug
resist
background
recent
emerg
novel
human
pathogen
sever
acut
respiratori
syndrom
coronaviru
china
rapid
nation
intern
spread
pose
global
health
emerg
march
publicli
declar
outbreak
pandem
week
viru
caus
thousand
death
worldwid
strongli
impact
global
economi
human
habit
envelop
ssrna
viru
belong
betacoronaviru
genu
includ
two
rna
virus
caus
recent
import
epidem
sever
acut
respiratori
syndrom
sar
caus
sarscov
middl
east
respiratori
syndrom
mer
merscov
noteworthi
evid
recent
provid
support
mortal
significantli
differ
depend
geograph
area
exampl
baud
colleagu
report
mortal
rate
three
time
higher
china
china
compar
ci
china
rate
reestim
divid
number
death
given
day
number
patient
confirm
infect
day
consid
data
rel
cumul
number
death
march
differ
viral
infect
rate
due
combin
factor
includ
differ
nation
strategi
adopt
peopl
movement
restrict
isol
quarantin
differ
genet
popul
herd
immun
mortal
differ
understand
viral
mutat
evolut
capabl
time
may
import
rna
virus
mutat
rate
dramat
high
million
time
higher
host
high
rate
correl
virul
modul
evolv
trait
consid
benefici
viral
adapt
wang
cowork
recent
character
variat
site
n
region
among
posit
show
mutat
rate
respect
prior
report
result
show
rapidli
move
across
countri
genom
new
mutat
hotspot
emerg
rna
viru
mutat
rate
contribut
viral
adapt
creat
balanc
integr
genet
inform
genom
variabl
biolog
character
viral
mutat
provid
preciou
insight
assess
viral
drug
resist
immun
escap
pathogenesi
relat
mechan
addit
viral
mutat
studi
crucial
design
new
vaccin
antivir
drug
diagnost
assay
viral
genom
mutagen
process
depend
viral
enzym
replic
nucleic
acid
influenc
proofread
capabl
andor
postrepl
nucleic
acid
repair
mutationgener
process
includ
host
enzym
spontan
nucleic
acid
damag
due
physic
chemic
mutagen
recombin
event
also
particular
genet
element
respons
product
new
variant
mutat
rate
modul
factor
determin
templat
sequenc
structur
involv
viral
replic
rnadepend
rna
polymeras
rdrp
multidomain
protein
abl
catalyz
rnatempl
depend
format
phosphodiest
bond
ribonucleotid
presenc
dival
metal
ion
virus
rna
polymeras
lack
proofread
capabl
except
nidoviral
order
coronaviru
genu
belong
stand
largest
rna
genom
nidovirus
character
complex
machineri
dedic
rna
synthesi
oper
nonstructur
protein
nsp
produc
cleavag
product
viral
polyprotein
facilit
viru
replic
transcript
rdrp
also
name
key
compon
replicationtranscript
machineri
share
high
homolog
compar
sarscov
suggest
function
mechan
action
might
well
conserv
confirm
recent
cryoem
structur
studi
obtain
sarscov
exonucleas
activ
proofread
function
report
exon
homologu
protein
found
well
exon
increas
fidel
rna
synthesi
correct
nucleotid
incorpor
error
made
rdrp
genet
inactiv
coronaviru
exon
result
decreas
replic
fidel
compar
wild
type
sarscov
moreov
kirchdoerf
colleagu
show
involv
format
supercomplex
rdrp
sarscov
confirm
also
recent
studi
unveil
structur
complex
complex
ensur
rdrp
process
becom
fundament
transcript
fidel
nevertheless
critic
sarscov
rdrp
residu
involv
exon
interact
still
identifi
rdrp
consid
among
primari
target
antivir
drug
develop
wide
varieti
virus
rdrp
inhibitor
consid
target
favipiravir
galidesivir
remdesivir
ribavirin
interestingli
dock
site
locat
proxim
catalyt
domain
rdrp
addit
possibl
drug
filibuvir
cepharanthin
simeprevir
tegobuvir
predict
potenti
inhibitor
rdrp
natur
occur
mutat
critic
residu
drug
efficaci
lead
drug
resist
phenomena
signific
loss
bind
affin
molecul
rdrp
focus
studi
mutat
order
assess
new
viral
variant
spread
across
countri
character
variant
could
lead
better
therapeut
treatment
vaccin
design
diagnost
approach
viru
refer
sequenc
use
analysi
deposit
januari
wu
cowork
formerli
call
wuhan
seafood
market
pneumonia
viru
wsm
http
wwwncbinlm
nihgovnucco
gisaid
databas
http
wwwgisai
dorg
filter
decemb
march
use
collect
complet
genom
differ
patient
around
world
ie
china
usa
canada
australia
unit
kingdom
germani
franc
japan
itali
switzerland
singapor
luxembourg
netherland
spain
portug
sweden
czech
republ
thailand
india
cambodia
hong
kong
finland
singapor
ireland
take
particular
consider
deposit
develop
european
outbreak
complet
genom
bp
analyz
clustal
omega
serial
cloner
blast
tool
use
conduct
multipl
sequenc
align
compar
wsm
sequenc
sequenc
isol
patient
wherea
swiss
model
ezmol
use
protein
model
statist
analysi
perform
r
softwar
first
check
normal
data
distribut
shapirowilk
test
express
continu
variabl
median
rang
minmax
categor
variabl
express
absolut
frequenc
percentag
nonparametr
mannwhitney
fisherexact
test
use
compar
number
mutat
per
genom
least
one
select
mutat
respect
group
genom
present
specif
mutat
analyz
pvalu
calcul
test
use
signific
level
databas
complet
patientisol
genom
sequenc
randomli
collect
gisaid
databas
align
compar
wsm
refer
genom
particular
patientisol
genom
submit
gisaid
databas
decemb
januari
februari
march
complet
genom
belong
patient
age
less
year
old
averag
age
patient
includ
databas
major
patient
men
divid
dataset
geograph
area
asia
oceania
europ
north
america
fig
within
area
perform
align
analysi
compar
patient
genom
refer
sequenc
asian
group
compris
genom
obtain
patient
locat
china
japan
southeastasia
india
oceanian
group
compris
genom
australian
patient
wherea
european
one
includ
everi
genom
obtain
patient
locat
one
european
state
spain
portug
unit
kingdom
netherland
itali
germani
switzerland
franc
luxemburg
sweden
finland
denmark
belgium
final
north
america
group
contain
genom
us
canadian
patient
evalu
distribut
mutat
differ
geograph
area
see
fig
calcul
mutat
frequenc
within
geograph
area
normal
number
genom
carri
given
mutat
per
geograph
area
confirm
occurr
mutat
locat
posit
moreov
highlight
presenc
addit
conserv
mutat
geograph
area
take
account
occur
time
databas
lower
occurr
report
mutat
found
posit
belong
rdrp
spike
protein
nucleocapsid
phosphoprotein
sequenc
respect
found
frequent
mutat
posit
silent
wherea
one
mutat
posit
outsid
orf
sequenc
hand
mutat
result
amino
acid
chang
follow
v
p
l
p
l
c
g
g
v
l
mutat
locat
posit
relat
doubl
codon
mutat
induc
substitut
two
amino
acid
name
r
k
g
r
new
amino
acid
present
v
p
l
p
l
c
g
v
l
similar
isoelectr
point
compar
origin
amino
acid
present
refer
protein
sequenc
except
mutat
posit
g
r
k
g
r
mutat
amino
acid
significantli
differ
isoelectr
point
studi
need
determin
whether
mutat
impact
protein
function
structur
note
number
occurr
mutat
increas
genom
found
asia
reach
maximum
genom
found
europ
north
america
also
note
viral
strain
found
europ
north
america
deriv
l
strain
origin
asia
order
determin
appear
mutat
analyz
genom
geograph
area
time
classifi
accord
time
sampl
collect
indic
gisaid
databas
accord
analysi
time
subgroup
defin
name
decemb
genom
patient
jan
genom
patient
jan
genom
patient
feb
genom
patient
feb
genom
patient
mar
genom
patient
number
mutat
normal
popul
taken
account
period
time
increas
time
viral
spread
asia
see
fig
mutat
observ
asian
genom
analyz
decemb
interestingli
differ
pattern
mutat
observ
europ
januari
februari
new
mutat
posit
emerg
depict
red
mutat
locat
rdrp
gene
also
start
februari
emerg
addit
new
mutat
ie
electr
blue
dark
green
respect
observ
time
also
note
increas
frequenc
mutat
orang
alreadi
present
midjanuari
moreov
differ
pattern
hotspot
mutat
clearli
distinguish
viral
genom
detect
north
american
patient
start
march
outbreak
posit
case
report
us
canada
group
three
novel
mutat
blue
purpl
light
pink
respect
report
interestingli
viral
genom
present
north
american
patient
carri
rdrp
mutat
carri
european
specif
mutat
given
import
rdrp
viabil
replic
rna
virus
mutat
gene
statist
less
like
occur
howev
case
polioviru
episod
drugresist
induc
point
mutat
rdrp
report
databas
first
appear
silent
rdrp
mutat
nt
manifest
februari
uk
england
differ
rdrp
mutat
nt
amino
acid
p
l
observ
first
time
itali
lombardi
februari
dramat
increas
number
european
infect
patient
report
websit
evalu
increasedecreas
mutat
frequenc
februari
across
differ
geograph
area
fig
particular
observ
strong
increas
genom
carri
mutat
affect
rdrp
europ
togeth
increas
genom
carri
mutat
mutat
mutat
see
upper
tabl
fig
next
analyz
genom
collect
februari
mutat
rdrp
gene
report
databas
first
time
purpos
analysi
divid
genom
two
group
group
contain
genom
mutat
posit
rdrp
n
north
america
european
group
without
rdrp
mutat
n
genom
group
show
increas
number
mutat
compar
group
particular
group
show
genom
two
mutat
genom
three
mutat
genom
four
mutat
genom
mutat
group
report
mutat
one
posit
regard
genom
group
carri
mutat
genom
singl
mutat
genom
two
mutat
genom
three
mutat
genom
four
mutat
genom
five
six
mutat
respect
group
report
mutat
locat
posit
distribut
two
group
term
number
mutat
statist
relev
fisherexact
test
p
valu
particular
group
significantli
differ
term
distribut
genom
number
mutat
fisherexact
test
p
fig
differ
instead
insignific
number
mutat
found
viral
strain
rdrp
mutat
median
point
mutat
rang
wherea
viral
strain
rdrp
mutat
median
mutat
rang
p
valu
mannwhitney
test
differ
distribut
two
group
rel
number
mutat
statist
signific
fig
also
analyz
frequent
mutat
detect
one
posit
europ
one
posit
north
america
viral
genom
carri
one
mutat
compar
viral
genom
without
mutat
use
mannwhitney
test
pairedgroup
comparison
analysi
genom
carri
mutat
posit
show
median
mutat
rang
wherea
genom
carri
none
median
mutat
rang
pvalu
mannwhitney
test
differ
statist
signific
impli
one
mutat
present
mutat
like
occur
among
mutat
site
analyz
rdrp
mutant
particularli
interest
given
enzym
directli
involv
viral
replic
fidel
determin
mutagen
capabl
due
high
homolog
rdrp
sarscov
align
rdrp
refer
sequenc
report
catalyt
site
sequenc
sarscov
rdrp
amino
acid
substitut
p
l
due
nucleotid
mutat
fall
outsid
catalyt
site
region
sarscov
report
interfac
domain
still
poorli
character
surfac
structur
supposedli
implic
interact
protein
may
regul
activ
rdrp
regard
wellknown
sarscov
rdrp
form
hollow
cylinderlik
supercomplex
confer
process
rdrp
addit
replic
supercomplex
interact
exonucleas
nidoviralestyp
proofread
capabl
activ
import
context
mutat
rate
control
fidel
rna
replic
howev
critic
rdrp
residu
involv
interact
still
identifi
reason
studi
need
assess
possibl
role
mutat
concern
rdrp
fidel
present
work
compar
refer
genom
export
gisaid
databas
aim
gain
import
insight
viru
mutat
occurr
time
within
differ
geograph
area
observ
februari
first
local
transmit
case
asia
report
viral
genom
present
differ
point
mutat
clearli
distinguish
within
differ
geograph
area
time
abl
identifi
three
recurr
mutat
europ
posit
differ
mutat
north
america
posit
far
mutat
detect
asia
number
occurr
well
median
valu
viru
point
mutat
regist
asia
increas
time
studi
found
rdrp
mutat
locat
posit
present
european
viral
genom
start
februari
associ
higher
number
point
mutat
compar
viral
genom
asia
given
rdrp
work
complex
machineri
includ
proofread
activ
cooper
viral
cofactor
like
exon
tempt
specul
mutat
contribut
impair
proofread
capabl
one
possibl
mechan
could
involv
minor
chang
rdrp
structur
without
affect
catalyt
activ
might
nonetheless
alter
bind
capabl
cofactor
exon
thu
alter
mutat
rate
could
explain
increas
number
mutat
observ
europ
sinc
februari
studi
need
determin
whether
observ
cluster
mutat
origin
molecular
mechan
studi
also
need
determin
whether
mutat
rdrp
result
increas
viral
replic
polymeras
inhibitor
current
test
clinic
studi
target
rdrp
includ
favipiravir
galidesivir
remdesivir
ribavirin
penciclovir
galidesivir
ponatinib
addit
drug
simeprevir
fda
approv
hcv
proteas
inhibitor
well
filibuvir
tegobuvir
rdrp
inhibitor
predict
bind
rdrp
molecular
dock
studi
particular
put
dock
site
identifi
hydrophob
cleft
close
mutat
site
p
l
correspond
mutat
identifi
studi
natur
occur
mutat
rdrp
potenti
lead
drugresist
phenomena
alreadi
observ
previous
altern
might
induc
signific
decreas
drugrdrp
complex
bind
affin
could
lead
differ
effect
antivir
treatment
mutat
present
reason
due
high
frequenc
rdrp
mutat
infect
popul
import
character
impact
mutat
activ
rdrp
suscept
antivir
drug
identifi
novel
mutat
hotspot
genom
sequenc
interestingli
appear
februari
european
patient
among
hotspot
one
mutat
posit
locat
within
rdrp
protein
associ
overal
increas
mutat
rate
silico
analysi
compar
annot
function
domain
sarscov
sequenc
show
particular
mutat
occur
socal
rdrp
interfac
domain
still
poorli
character
surfac
structur
involv
proteinprotein
interact
role
rdrp
interfac
domain
requir
investig
particular
effect
mutat
posit
interact
cofactor
exon
possibl
affect
proofread
activ
potenti
alter
mutat
rate
also
essenti
understand
describ
mutat
could
result
emerg
drugresist
viral
phenotyp
data
may
help
develop
diagnost
therapeut
strategi
studi
potenti
drug
resist
mechan
